BridgeMD
New treatment option for Blood Pressure
Official title Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents
ClinicalTrials.gov ID: NCT05874479
What this study is testing
- What it's testing
- Fine particulate matter \<2.5 µm (PM2.5) air pollution is the fifth leading risk factor for global mortality, with the largest portion of deaths due to cardiovascular disease (CVD). While several mechanisms are responsible, PM2.5-induced elevations in blood pressure (BP) may be relevant.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- self-reported nonsmokers living in a nonsmoking household.
- adults living with hypertension (HTN) from NYC public housing.
You likely can't join if
- History of major known arrhythmias (e.g. atrial flutter or fibrillation, ventricular tachycardia).
- Screening systolic BP ≥160 mm Hg or diastolic BP ≥100 mm Hg (i.e. severe hypertension by the 2017 ACC/AHA BP guideline).
- A change in drug regimen in the prior 2 weeks or a planned change in drug regimen during the first 30 days for those taking antihypertensive...
- Current smoking or living with an active smoker who smokes indoors
- Planned travel out of NYC for ≥2 weeks in next 6 months
- Incarcerated
See the full eligibility criteria
- self-reported nonsmokers living in a nonsmoking household.
- adults living with hypertension (HTN) from NYC public housing.
- History of major known arrhythmias (e.g. atrial flutter or fibrillation, ventricular tachycardia).
- Screening systolic BP ≥160 mm Hg or diastolic BP ≥100 mm Hg (i.e. severe hypertension by the 2017 ACC/AHA BP guideline).
- A change in drug regimen in the prior 2 weeks or a planned change in drug regimen during the first 30 days for those taking antihypertensive medication.
- Current smoking or living with an active smoker who smokes indoors
- Planned travel out of NYC for ≥2 weeks in next 6 months
- Incarcerated
- Pregnant
- Unable/unwilling to consent
- Established cardiovascular disease
- End-stage renal disease (chronic kidney disease stage IV or on dialysis)
- Barrier to technology use (e.g., visual or hearing impairment)
- Lung disease requiring oxygen
- Cancer receiving treatment
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.